Drug Trial Radar · NCT06970483
Comparison of the Efficacy of Misoprostol and Tranexamic Acid for Postpartum Hemorrhage Prophylaxis in Cesarean Delivery
Last checked: Nov 20, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
192
Actual
Start
Dec 1, 2023
Primary completion
Dec 1, 2024
Study completion Dec 1, 2024
Sponsor
- Lead sponsor
- Ankara Etlik City HospitalGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- First posted
- May 14, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Postpartum hemorrhage (PPH) is an obstetric emergency, with an estimated incidence ranging from 2.8% to 7.9%. Recent studies indicate an increasing trend in the frequency of PPH.Although it is more commonly seen in developing countries, it remains a significant cause of maternal morbidity and mortality worldwide. Therefore, early diagnosis and prompt, accurate intervention are critically important. Despite the rising incidence of PPH, maternal mortality rates have declined. This improvement is largely attributed to better identification of risk factors, timely diagnosis, and effective intervention. To prevent PPH globally, active management of the third stage of labor has been widely implemented. This approach includes the use of pharmacologic agents, uterine massage, and controlled traction for placental delivery.Among pharmacological agents, the most commonly used include oxytocin, ergot alkaloids (e.g., ergometrine), tranexamic acid, prostaglandin E1 (misoprostol), prostaglandin F2α, and oxytocin analogues (e.g., carbetocin).Oxytocin is the most widely used agent for PPH prophylaxis. The aim of this study is to compare the efficacy of tranexamic acid and misoprostol in the prophylaxis of postpartum hemorrhage.
Conditions
- Postpartum Hemorrhage
- Cesarean Section Complications
- Delivery Complication
Interventions
Tranexamic acidDrug
Transamine1 gram was administered intravenously during the lower segment incision.
Misoprostol 200mcg TabDrug
Cytotec 400 micrograms were administered sublingually immediately after delivery of the baby and clamping of the umbilical cord.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Comparison of patients' preoperative and postoperative hemogram levelsTime frame: 24 hours
- Comparison of patients' preoperative and postoperative hematocrit levelsTime frame: 24 hours
- Comparison of patients' postoperative shock indicesTime frame: 24 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Etlik City Hospital
Ankara, Turkey (Türkiye)
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.